(Q50752354)

English

Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo.

scientific article published on 30 September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. (English)

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

author name string

Tuanzhu Ha

1

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Fang Hua

2

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Yuehua Li

3

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Jing Ma

4

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Xiang Gao

5

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Jim Kelley

6

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Aiqiu Zhao

7

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Georges E Haddad

8

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

David L Williams

9

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

I William Browder

10

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Race L Kao

11

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Chuanfu Li

12

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

publication date

30 September 2005

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

290

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

3

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

H985-94

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

MyD88, an adapter protein involved in interleukin-1 signaling

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

A20 is dynamically regulated in the heart and inhibits the hypertrophic response

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Dominant negative MyD88 proteins inhibit interleukin-1beta /interferon-gamma -mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

NF-kappaB activation is required for the development of cardiac hypertrophy in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Myocyte death, growth, and regeneration in cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Myocyte hypertrophy and apoptosis: a balancing act.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

MyD88: an adapter that recruits IRAK to the IL-1 receptor complex

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00720.2005

21 January 2018

Identifiers

10.1152/AJPHEART.00720.2005

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/16199478

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50752354&oldid=827759684"